Gene Symbol | Gene ID | Gene Info |
---|---|---|
HOXB4
|
ENSG00000182742.5 | homeobox B4 |
LHX9
|
ENSG00000143355.11 | LIM homeobox 9 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr17_46658327_46658478 | HOXB4 | 929 | 0.236935 | 0.41 | 2.8e-01 | Click! |
chr17_46658149_46658300 | HOXB4 | 751 | 0.289329 | -0.23 | 5.5e-01 | Click! |
chr17_46657344_46657617 | HOXB4 | 7 | 0.648893 | 0.15 | 7.0e-01 | Click! |
chr1_197879409_197879560 | LHX9 | 2137 | 0.365782 | 0.70 | 3.5e-02 | Click! |
chr1_197999710_197999861 | LHX9 | 113256 | 0.063457 | 0.69 | 4.0e-02 | Click! |
chr1_197877951_197878134 | LHX9 | 3579 | 0.278863 | 0.68 | 4.3e-02 | Click! |
chr1_197885056_197885605 | LHX9 | 363 | 0.900744 | 0.56 | 1.1e-01 | Click! |
chr1_197880988_197881139 | LHX9 | 558 | 0.809868 | 0.53 | 1.4e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr7_129933276_129933885 | 2.13 |
CPA4 |
carboxypeptidase A4 |
461 |
0.76 |
chr4_157891142_157892336 | 1.98 |
PDGFC |
platelet derived growth factor C |
316 |
0.91 |
chr9_18474095_18474958 | 1.68 |
ADAMTSL1 |
ADAMTS-like 1 |
295 |
0.95 |
chr7_17720120_17720505 | 1.61 |
SNX13 |
sorting nexin 13 |
259779 |
0.02 |
chr15_96878987_96879612 | 1.45 |
ENSG00000222651 |
. |
2809 |
0.21 |
chr1_87799796_87800719 | 1.35 |
LMO4 |
LIM domain only 4 |
2906 |
0.4 |
chr1_225839301_225840394 | 1.16 |
ENAH |
enabled homolog (Drosophila) |
571 |
0.78 |
chr3_87036535_87037613 | 1.12 |
VGLL3 |
vestigial like 3 (Drosophila) |
2778 |
0.42 |
chr18_53089837_53090372 | 1.10 |
TCF4 |
transcription factor 4 |
361 |
0.89 |
chr12_115135696_115136278 | 1.08 |
TBX3 |
T-box 3 |
14018 |
0.21 |
chr20_37614039_37614271 | 1.06 |
DHX35 |
DEAH (Asp-Glu-Ala-His) box polypeptide 35 |
23168 |
0.18 |
chr7_92327766_92328157 | 1.05 |
ENSG00000206763 |
. |
3167 |
0.33 |
chr9_89952337_89952906 | 0.99 |
ENSG00000212421 |
. |
77256 |
0.11 |
chr3_33318777_33319866 | 0.97 |
FBXL2 |
F-box and leucine-rich repeat protein 2 |
353 |
0.91 |
chr21_17909068_17909746 | 0.97 |
ENSG00000207638 |
. |
2002 |
0.33 |
chr10_69831641_69832005 | 0.97 |
HERC4 |
HECT and RLD domain containing E3 ubiquitin protein ligase 4 |
2071 |
0.33 |
chr16_4424352_4424847 | 0.95 |
VASN |
vasorin |
2750 |
0.17 |
chr4_141015619_141015856 | 0.95 |
RP11-392B6.1 |
|
33432 |
0.2 |
chr3_114477857_114478359 | 0.95 |
ZBTB20 |
zinc finger and BTB domain containing 20 |
10 |
0.99 |
chr11_131780111_131780399 | 0.92 |
NTM |
neurotrimin |
642 |
0.77 |
chr18_53090404_53090609 | 0.92 |
TCF4 |
transcription factor 4 |
763 |
0.7 |
chrX_114829080_114829277 | 0.91 |
PLS3 |
plastin 3 |
1313 |
0.48 |
chr3_79066759_79066910 | 0.91 |
ROBO1 |
roundabout, axon guidance receptor, homolog 1 (Drosophila) |
860 |
0.75 |
chr4_89977525_89978081 | 0.91 |
FAM13A |
family with sequence similarity 13, member A |
508 |
0.85 |
chr4_77506894_77507309 | 0.91 |
ENSG00000265314 |
. |
10397 |
0.17 |
chr13_76217437_76217800 | 0.90 |
LMO7 |
LIM domain 7 |
7159 |
0.18 |
chr4_134070427_134071051 | 0.90 |
PCDH10 |
protocadherin 10 |
269 |
0.96 |
chr16_62068318_62068835 | 0.89 |
CDH8 |
cadherin 8, type 2 |
462 |
0.9 |
chr3_88191159_88191414 | 0.89 |
ZNF654 |
zinc finger protein 654 |
3032 |
0.24 |
chr21_36254420_36254945 | 0.87 |
RUNX1 |
runt-related transcription factor 1 |
4798 |
0.34 |
chr1_68697735_68698156 | 0.87 |
WLS |
wntless Wnt ligand secretion mediator |
18 |
0.98 |
chr10_24754741_24755189 | 0.87 |
KIAA1217 |
KIAA1217 |
495 |
0.84 |
chr1_31480017_31480289 | 0.86 |
PUM1 |
pumilio RNA-binding family member 1 |
12202 |
0.19 |
chr7_95402477_95402695 | 0.86 |
DYNC1I1 |
dynein, cytoplasmic 1, intermediate chain 1 |
670 |
0.81 |
chr11_106239153_106239583 | 0.85 |
RP11-680E19.1 |
|
104326 |
0.08 |
chr11_27740250_27740471 | 0.84 |
BDNF |
brain-derived neurotrophic factor |
934 |
0.68 |
chr6_85823864_85824548 | 0.84 |
NT5E |
5'-nucleotidase, ecto (CD73) |
335603 |
0.01 |
chr7_98970111_98970529 | 0.84 |
ARPC1B |
actin related protein 2/3 complex, subunit 1B, 41kDa |
1552 |
0.28 |
chr8_89311514_89311910 | 0.83 |
RP11-586K2.1 |
|
27353 |
0.2 |
chr12_66286178_66286489 | 0.83 |
RP11-366L20.2 |
Uncharacterized protein |
10386 |
0.18 |
chr10_4285552_4285907 | 0.82 |
ENSG00000207124 |
. |
271415 |
0.02 |
chr1_243415347_243415602 | 0.82 |
CEP170 |
centrosomal protein 170kDa |
1148 |
0.47 |
chr3_134050593_134051228 | 0.82 |
AMOTL2 |
angiomotin like 2 |
39844 |
0.16 |
chr2_207998546_207999225 | 0.81 |
KLF7 |
Kruppel-like factor 7 (ubiquitous) |
24 |
0.98 |
chr8_116675050_116675578 | 0.80 |
TRPS1 |
trichorhinophalangeal syndrome I |
1409 |
0.6 |
chr8_127837007_127837644 | 0.79 |
ENSG00000212451 |
. |
153558 |
0.04 |
chr9_16726683_16727481 | 0.79 |
RP11-62F24.2 |
|
270 |
0.85 |
chr20_10521227_10521501 | 0.79 |
SLX4IP |
SLX4 interacting protein |
105413 |
0.06 |
chr6_27060216_27060434 | 0.79 |
ENSG00000222800 |
. |
17434 |
0.13 |
chr15_88020923_88021173 | 0.78 |
ENSG00000207150 |
. |
3528 |
0.4 |
chr18_60385543_60385694 | 0.78 |
PHLPP1 |
PH domain and leucine rich repeat protein phosphatase 1 |
2935 |
0.28 |
chr4_107956832_107957922 | 0.78 |
DKK2 |
dickkopf WNT signaling pathway inhibitor 2 |
77 |
0.99 |
chr3_79216626_79216907 | 0.76 |
ROBO1 |
roundabout, axon guidance receptor, homolog 1 (Drosophila) |
148157 |
0.05 |
chr12_89845524_89845923 | 0.75 |
POC1B |
POC1 centriolar protein B |
45311 |
0.13 |
chr15_97778812_97779147 | 0.75 |
ENSG00000242863 |
. |
117748 |
0.06 |
chr12_50665639_50665877 | 0.74 |
LIMA1 |
LIM domain and actin binding 1 |
11509 |
0.13 |
chr2_46933523_46933944 | 0.74 |
SOCS5 |
suppressor of cytokine signaling 5 |
7407 |
0.22 |
chr5_120114861_120115414 | 0.74 |
ENSG00000222609 |
. |
68602 |
0.14 |
chr15_30112674_30113382 | 0.74 |
TJP1 |
tight junction protein 1 |
723 |
0.64 |
chr8_37350646_37351319 | 0.74 |
RP11-150O12.6 |
|
23557 |
0.24 |
chr2_157657104_157657488 | 0.73 |
ENSG00000263848 |
. |
214473 |
0.02 |
chr7_24988449_24988600 | 0.72 |
OSBPL3 |
oxysterol binding protein-like 3 |
30812 |
0.21 |
chr1_45083000_45083241 | 0.72 |
RNF220 |
ring finger protein 220 |
8878 |
0.17 |
chr6_163817634_163818149 | 0.72 |
QKI |
QKI, KH domain containing, RNA binding |
17784 |
0.29 |
chr12_47470653_47470804 | 0.72 |
PCED1B |
PC-esterase domain containing 1B |
2658 |
0.29 |
chr2_3626466_3626991 | 0.71 |
ENSG00000252531 |
. |
1432 |
0.27 |
chr2_197831667_197831951 | 0.71 |
ANKRD44 |
ankyrin repeat domain 44 |
33417 |
0.18 |
chr6_5471426_5471612 | 0.70 |
RP1-232P20.1 |
|
13211 |
0.27 |
chr3_114404388_114404544 | 0.70 |
ENSG00000264623 |
. |
57906 |
0.14 |
chr8_30243504_30243875 | 0.70 |
RBPMS-AS1 |
RBPMS antisense RNA 1 |
772 |
0.48 |
chr3_59101471_59101696 | 0.69 |
C3orf67 |
chromosome 3 open reading frame 67 |
65773 |
0.15 |
chr5_92908415_92908864 | 0.69 |
ENSG00000237187 |
. |
1590 |
0.42 |
chr9_12859535_12860149 | 0.69 |
ENSG00000222658 |
. |
25478 |
0.2 |
chr7_157140270_157140421 | 0.68 |
DNAJB6 |
DnaJ (Hsp40) homolog, subfamily B, member 6 |
7830 |
0.25 |
chr8_93114852_93115389 | 0.68 |
RUNX1T1 |
runt-related transcription factor 1; translocated to, 1 (cyclin D-related) |
334 |
0.94 |
chr20_46412966_46413363 | 0.68 |
SULF2 |
sulfatase 2 |
1069 |
0.59 |
chr1_234635711_234635917 | 0.67 |
TARBP1 |
TAR (HIV-1) RNA binding protein 1 |
20965 |
0.2 |
chr5_82767889_82768074 | 0.67 |
VCAN |
versican |
237 |
0.96 |
chr1_236073367_236073780 | 0.67 |
ENSG00000206803 |
. |
5142 |
0.2 |
chr8_56805751_56805987 | 0.67 |
RP11-318K15.2 |
|
285 |
0.88 |
chr4_77611462_77611724 | 0.66 |
AC107072.2 |
|
52817 |
0.12 |
chr12_94580963_94581249 | 0.66 |
RP11-74K11.2 |
|
1286 |
0.5 |
chr12_56917781_56918152 | 0.66 |
RBMS2 |
RNA binding motif, single stranded interacting protein 2 |
2183 |
0.23 |
chr18_52495652_52496658 | 0.66 |
RAB27B |
RAB27B, member RAS oncogene family |
725 |
0.77 |
chr12_120246427_120246712 | 0.66 |
CIT |
citron (rho-interacting, serine/threonine kinase 21) |
5382 |
0.27 |
chr12_80081544_80081908 | 0.66 |
PAWR |
PRKC, apoptosis, WT1, regulator |
2134 |
0.41 |
chr1_68214173_68214559 | 0.65 |
ENSG00000238778 |
. |
23970 |
0.19 |
chr11_111849006_111849202 | 0.64 |
DIXDC1 |
DIX domain containing 1 |
1071 |
0.39 |
chr15_99788624_99789059 | 0.64 |
TTC23 |
tetratricopeptide repeat domain 23 |
895 |
0.51 |
chr4_108746841_108747185 | 0.64 |
SGMS2 |
sphingomyelin synthase 2 |
649 |
0.76 |
chr5_173000019_173000195 | 0.63 |
CTB-33O18.3 |
|
6539 |
0.26 |
chr9_126331371_126331654 | 0.63 |
ENSG00000222722 |
. |
16224 |
0.24 |
chr4_128459981_128460192 | 0.63 |
INTU |
inturned planar cell polarity protein |
84340 |
0.11 |
chr8_97507706_97507857 | 0.63 |
SDC2 |
syndecan 2 |
1545 |
0.51 |
chr4_6887879_6888223 | 0.63 |
TBC1D14 |
TBC1 domain family, member 14 |
22918 |
0.18 |
chr4_140808579_140808865 | 0.63 |
MAML3 |
mastermind-like 3 (Drosophila) |
2484 |
0.4 |
chr3_114169976_114170457 | 0.62 |
ZBTB20 |
zinc finger and BTB domain containing 20 |
3314 |
0.33 |
chr9_100069620_100070257 | 0.62 |
CCDC180 |
coiled-coil domain containing 180 |
3 |
0.98 |
chr9_130615060_130615211 | 0.62 |
ENG |
endoglin |
1780 |
0.16 |
chr3_110791913_110792064 | 0.62 |
PVRL3 |
poliovirus receptor-related 3 |
973 |
0.53 |
chr18_42313149_42313495 | 0.62 |
SETBP1 |
SET binding protein 1 |
36193 |
0.24 |
chr1_63212144_63212320 | 0.62 |
ATG4C |
autophagy related 4C, cysteine peptidase |
37574 |
0.17 |
chr6_27182410_27182602 | 0.62 |
PRSS16 |
protease, serine, 16 (thymus) |
32974 |
0.13 |
chr4_79473579_79473973 | 0.62 |
ANXA3 |
annexin A3 |
655 |
0.79 |
chr10_62331691_62331925 | 0.61 |
ANK3 |
ankyrin 3, node of Ranvier (ankyrin G) |
613 |
0.85 |
chr13_24146066_24146217 | 0.61 |
TNFRSF19 |
tumor necrosis factor receptor superfamily, member 19 |
1338 |
0.59 |
chr13_73081776_73081993 | 0.61 |
ENSG00000251715 |
. |
47145 |
0.15 |
chr12_49581087_49581445 | 0.61 |
TUBA1A |
tubulin, alpha 1a |
25 |
0.96 |
chr4_124339424_124339730 | 0.61 |
SPRY1 |
sprouty homolog 1, antagonist of FGF signaling (Drosophila) |
18454 |
0.3 |
chr3_172035927_172036370 | 0.60 |
AC092964.1 |
Uncharacterized protein |
1930 |
0.38 |
chr2_242605024_242605218 | 0.60 |
ATG4B |
autophagy related 4B, cysteine peptidase |
890 |
0.44 |
chr9_22008020_22008450 | 0.60 |
CDKN2B |
cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4) |
717 |
0.61 |
chr4_183370400_183371073 | 0.60 |
TENM3 |
teneurin transmembrane protein 3 |
584 |
0.84 |
chr7_70201396_70202343 | 0.60 |
AUTS2 |
autism susceptibility candidate 2 |
7744 |
0.34 |
chr3_105657205_105657471 | 0.60 |
CBLB |
Cbl proto-oncogene B, E3 ubiquitin protein ligase |
68942 |
0.15 |
chr11_114167823_114168031 | 0.60 |
NNMT |
nicotinamide N-methyltransferase |
158 |
0.96 |
chr8_48648492_48649280 | 0.60 |
CEBPD |
CCAAT/enhancer binding protein (C/EBP), delta |
2762 |
0.26 |
chr20_50384318_50384901 | 0.60 |
ATP9A |
ATPase, class II, type 9A |
258 |
0.94 |
chr7_30202699_30202958 | 0.59 |
AC007036.5 |
|
5681 |
0.19 |
chr18_20612011_20612377 | 0.59 |
ENSG00000223023 |
. |
7635 |
0.17 |
chr1_28390431_28390759 | 0.58 |
EYA3 |
eyes absent homolog 3 (Drosophila) |
5997 |
0.17 |
chr11_12849556_12849989 | 0.58 |
RP11-47J17.3 |
|
4558 |
0.23 |
chr17_19998529_19998923 | 0.58 |
SPECC1 |
sperm antigen with calponin homology and coiled-coil domains 1 |
279 |
0.92 |
chr1_25525114_25525400 | 0.58 |
RP4-706G24.1 |
|
9373 |
0.19 |
chr15_96869332_96869483 | 0.58 |
NR2F2 |
nuclear receptor subfamily 2, group F, member 2 |
240 |
0.83 |
chr8_25868117_25868310 | 0.58 |
EBF2 |
early B-cell factor 2 |
30791 |
0.24 |
chr1_186588107_186588258 | 0.58 |
PTGS2 |
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
61377 |
0.14 |
chr19_30719241_30719606 | 0.58 |
ZNF536 |
zinc finger protein 536 |
2 |
0.73 |
chr1_179111271_179111703 | 0.58 |
ABL2 |
c-abl oncogene 2, non-receptor tyrosine kinase |
692 |
0.72 |
chr11_126870778_126870987 | 0.58 |
KIRREL3 |
kin of IRRE like 3 (Drosophila) |
176 |
0.93 |
chr6_143193241_143193570 | 0.58 |
HIVEP2 |
human immunodeficiency virus type I enhancer binding protein 2 |
35221 |
0.21 |
chr17_26372112_26372274 | 0.58 |
NLK |
nemo-like kinase |
2328 |
0.24 |
chr12_28120085_28120268 | 0.58 |
PTHLH |
parathyroid hormone-like hormone |
2251 |
0.33 |
chr2_202904203_202904368 | 0.58 |
FZD7 |
frizzled family receptor 7 |
4975 |
0.19 |
chr4_108745368_108745519 | 0.57 |
SGMS2 |
sphingomyelin synthase 2 |
276 |
0.93 |
chr2_38295840_38295991 | 0.57 |
RMDN2-AS1 |
RMDN2 antisense RNA 1 |
1731 |
0.34 |
chr10_104102183_104102477 | 0.57 |
NFKB2 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100) |
51537 |
0.08 |
chr4_77610213_77610516 | 0.57 |
AC107072.2 |
|
51588 |
0.12 |
chr17_45698884_45699286 | 0.57 |
NPEPPS |
aminopeptidase puromycin sensitive |
3369 |
0.19 |
chr6_134492010_134492298 | 0.56 |
SGK1 |
serum/glucocorticoid regulated kinase 1 |
3848 |
0.24 |
chr2_109210392_109210708 | 0.56 |
LIMS1 |
LIM and senescent cell antigen-like domains 1 |
5628 |
0.26 |
chr15_60667686_60667929 | 0.56 |
ANXA2 |
annexin A2 |
1103 |
0.63 |
chr7_28726429_28726958 | 0.56 |
CREB5 |
cAMP responsive element binding protein 5 |
1095 |
0.68 |
chr7_95107815_95108198 | 0.56 |
ASB4 |
ankyrin repeat and SOCS box containing 4 |
7207 |
0.2 |
chr7_102553717_102554092 | 0.56 |
LRRC17 |
leucine rich repeat containing 17 |
452 |
0.83 |
chr10_33622034_33622426 | 0.56 |
NRP1 |
neuropilin 1 |
1080 |
0.63 |
chr15_96884556_96884898 | 0.56 |
ENSG00000222651 |
. |
8237 |
0.16 |
chr5_96180027_96180310 | 0.56 |
CTD-2260A17.2 |
Uncharacterized protein |
29147 |
0.12 |
chr4_112244997_112245242 | 0.56 |
ENSG00000200963 |
. |
7449 |
0.34 |
chr15_59663421_59663716 | 0.56 |
FAM81A |
family with sequence similarity 81, member A |
1324 |
0.28 |
chr18_77225876_77226142 | 0.55 |
AC018445.1 |
Uncharacterized protein |
50048 |
0.15 |
chr9_40632604_40633916 | 0.55 |
SPATA31A3 |
SPATA31 subfamily A, member 3 |
67031 |
0.14 |
chr5_174178214_174178699 | 0.55 |
ENSG00000266890 |
. |
281 |
0.94 |
chr4_57975072_57975270 | 0.55 |
IGFBP7-AS1 |
IGFBP7 antisense RNA 1 |
757 |
0.52 |
chr9_96902091_96902301 | 0.55 |
ENSG00000199165 |
. |
36038 |
0.13 |
chr5_57751342_57751690 | 0.55 |
PLK2 |
polo-like kinase 2 |
4571 |
0.26 |
chr4_146729352_146729578 | 0.55 |
RP11-181K12.2 |
|
24805 |
0.2 |
chr9_96819103_96819334 | 0.55 |
PTPDC1 |
protein tyrosine phosphatase domain containing 1 |
26142 |
0.21 |
chr17_46970773_46971045 | 0.55 |
ATP5G1 |
ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C1 (subunit 9) |
234 |
0.87 |
chr22_29106398_29106549 | 0.55 |
CHEK2 |
checkpoint kinase 2 |
1446 |
0.37 |
chr8_142048186_142048475 | 0.55 |
PTK2 |
protein tyrosine kinase 2 |
36121 |
0.17 |
chr2_161522670_161522919 | 0.54 |
RBMS1 |
RNA binding motif, single stranded interacting protein 1 |
172489 |
0.03 |
chr16_27378896_27379134 | 0.54 |
IL4R |
interleukin 4 receptor |
15019 |
0.19 |
chr12_22059820_22060034 | 0.54 |
ABCC9 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 9 |
3985 |
0.3 |
chr7_82188634_82189045 | 0.54 |
CACNA2D1 |
calcium channel, voltage-dependent, alpha 2/delta subunit 1 |
115725 |
0.07 |
chr16_14279913_14280368 | 0.54 |
MKL2 |
MKL/myocardin-like 2 |
434 |
0.86 |
chr4_139011510_139011683 | 0.54 |
ENSG00000250033 |
. |
1428 |
0.6 |
chr20_4953796_4953984 | 0.54 |
SLC23A2 |
solute carrier family 23 (ascorbic acid transporter), member 2 |
28255 |
0.16 |
chr11_75315135_75315603 | 0.54 |
CTD-2530H12.8 |
|
7054 |
0.14 |
chr5_72327202_72327380 | 0.54 |
ENSG00000200833 |
. |
68609 |
0.09 |
chr15_48436377_48436744 | 0.54 |
MYEF2 |
myelin expression factor 2 |
4963 |
0.17 |
chr11_17096963_17097114 | 0.53 |
ENSG00000201403 |
. |
377 |
0.59 |
chr10_129809540_129809846 | 0.53 |
PTPRE |
protein tyrosine phosphatase, receptor type, E |
13303 |
0.26 |
chr4_151500337_151500655 | 0.53 |
RP11-1336O20.2 |
|
255 |
0.93 |
chr5_3597777_3597928 | 0.53 |
IRX1 |
iroquois homeobox 1 |
1684 |
0.41 |
chr8_32085203_32085460 | 0.53 |
NRG1-IT2 |
NRG1 intronic transcript 2 (non-protein coding) |
6887 |
0.22 |
chr6_144016553_144016704 | 0.53 |
PHACTR2 |
phosphatase and actin regulator 2 |
17423 |
0.25 |
chr11_46237993_46238166 | 0.53 |
CTD-2589M5.4 |
|
58019 |
0.1 |
chr5_127149430_127149726 | 0.53 |
CTC-548H10.2 |
|
149857 |
0.04 |
chr5_83680805_83681167 | 0.53 |
CTD-2269F5.1 |
|
311 |
0.56 |
chr2_58266503_58266768 | 0.53 |
VRK2 |
vaccinia related kinase 2 |
7094 |
0.27 |
chr5_88178054_88178448 | 0.53 |
MEF2C |
myocyte enhancer factor 2C |
713 |
0.52 |
chr12_24103066_24103383 | 0.53 |
SOX5 |
SRY (sex determining region Y)-box 5 |
587 |
0.86 |
chr3_174675589_174675952 | 0.53 |
NAALADL2 |
N-acetylated alpha-linked acidic dipeptidase-like 2 |
98700 |
0.09 |
chr9_104248314_104249564 | 0.52 |
TMEM246 |
transmembrane protein 246 |
460 |
0.79 |
chr4_79215331_79215502 | 0.52 |
FRAS1 |
Fraser syndrome 1 |
39016 |
0.21 |
chr4_182568542_182568740 | 0.52 |
ENSG00000251742 |
. |
187620 |
0.03 |
chr2_230138192_230138530 | 0.52 |
PID1 |
phosphotyrosine interaction domain containing 1 |
2360 |
0.4 |
chr13_80912572_80913077 | 0.52 |
SPRY2 |
sprouty homolog 2 (Drosophila) |
970 |
0.67 |
chr8_16689434_16690090 | 0.52 |
ENSG00000264092 |
. |
31243 |
0.24 |
chr14_101867418_101867569 | 0.52 |
ENSG00000258498 |
. |
159266 |
0.02 |
chr8_57086542_57086822 | 0.52 |
PLAG1 |
pleiomorphic adenoma gene 1 |
37156 |
0.12 |
chr20_52271481_52272252 | 0.52 |
ENSG00000238468 |
. |
13431 |
0.22 |
chr6_38230060_38230313 | 0.52 |
ENSG00000200706 |
. |
55136 |
0.16 |
chr4_41215270_41215769 | 0.52 |
APBB2 |
amyloid beta (A4) precursor protein-binding, family B, member 2 |
956 |
0.59 |
chr1_196577911_196578299 | 0.52 |
KCNT2 |
potassium channel, subfamily T, member 2 |
250 |
0.94 |
chrX_114828631_114828846 | 0.52 |
PLS3 |
plastin 3 |
873 |
0.64 |
chr1_57041430_57041821 | 0.51 |
PPAP2B |
phosphatidic acid phosphatase type 2B |
3616 |
0.34 |
chr12_16500369_16500557 | 0.51 |
MGST1 |
microsomal glutathione S-transferase 1 |
116 |
0.98 |
chr6_130690776_130691119 | 0.51 |
TMEM200A |
transmembrane protein 200A |
4068 |
0.25 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 1.8 | GO:0050923 | regulation of negative chemotaxis(GO:0050923) |
0.5 | 1.5 | GO:0060839 | endothelial cell fate commitment(GO:0060839) |
0.4 | 1.7 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.3 | 0.8 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.2 | 0.7 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
0.2 | 0.9 | GO:0060013 | righting reflex(GO:0060013) |
0.2 | 0.6 | GO:0032509 | endosome transport via multivesicular body sorting pathway(GO:0032509) |
0.2 | 0.8 | GO:0060437 | lung growth(GO:0060437) |
0.2 | 1.2 | GO:0097061 | dendritic spine morphogenesis(GO:0060997) regulation of dendritic spine morphogenesis(GO:0061001) dendritic spine organization(GO:0097061) |
0.2 | 0.5 | GO:0055098 | response to low-density lipoprotein particle(GO:0055098) |
0.2 | 0.5 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
0.2 | 0.2 | GO:0042501 | serine phosphorylation of STAT protein(GO:0042501) |
0.2 | 1.0 | GO:0008354 | germ cell migration(GO:0008354) |
0.2 | 0.6 | GO:0048539 | bone marrow development(GO:0048539) |
0.2 | 0.2 | GO:0003402 | planar cell polarity pathway involved in axis elongation(GO:0003402) |
0.1 | 0.4 | GO:0060596 | mammary placode formation(GO:0060596) |
0.1 | 0.1 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
0.1 | 0.4 | GO:0010766 | negative regulation of sodium ion transport(GO:0010766) |
0.1 | 0.3 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
0.1 | 0.4 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.1 | 0.4 | GO:0060677 | ureteric bud elongation(GO:0060677) |
0.1 | 0.4 | GO:0071694 | sequestering of extracellular ligand from receptor(GO:0035581) sequestering of TGFbeta in extracellular matrix(GO:0035583) protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
0.1 | 1.1 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.1 | 0.1 | GO:0048845 | venous blood vessel morphogenesis(GO:0048845) |
0.1 | 0.5 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
0.1 | 0.5 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.1 | 0.5 | GO:0010107 | potassium ion import(GO:0010107) |
0.1 | 0.6 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.1 | 0.1 | GO:0060449 | bud elongation involved in lung branching(GO:0060449) |
0.1 | 0.3 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.1 | 0.5 | GO:2000095 | regulation of non-canonical Wnt signaling pathway(GO:2000050) regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000095) |
0.1 | 0.3 | GO:0022605 | oogenesis stage(GO:0022605) |
0.1 | 0.4 | GO:0010667 | striated muscle cell apoptotic process(GO:0010658) cardiac muscle cell apoptotic process(GO:0010659) regulation of striated muscle cell apoptotic process(GO:0010662) negative regulation of striated muscle cell apoptotic process(GO:0010664) regulation of cardiac muscle cell apoptotic process(GO:0010665) negative regulation of cardiac muscle cell apoptotic process(GO:0010667) |
0.1 | 0.4 | GO:0009169 | purine nucleoside monophosphate catabolic process(GO:0009128) ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
0.1 | 0.6 | GO:0061384 | heart trabecula formation(GO:0060347) heart trabecula morphogenesis(GO:0061384) |
0.1 | 0.7 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
0.1 | 2.8 | GO:0048010 | vascular endothelial growth factor receptor signaling pathway(GO:0048010) |
0.1 | 0.4 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
0.1 | 0.4 | GO:0061004 | pattern specification involved in kidney development(GO:0061004) renal system pattern specification(GO:0072048) pattern specification involved in metanephros development(GO:0072268) |
0.1 | 0.4 | GO:0043312 | neutrophil activation involved in immune response(GO:0002283) neutrophil degranulation(GO:0043312) |
0.1 | 0.1 | GO:0071481 | cellular response to X-ray(GO:0071481) |
0.1 | 0.3 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
0.1 | 0.2 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
0.1 | 0.9 | GO:0034446 | substrate adhesion-dependent cell spreading(GO:0034446) |
0.1 | 0.3 | GO:0009756 | carbohydrate mediated signaling(GO:0009756) |
0.1 | 0.3 | GO:0033262 | regulation of nuclear cell cycle DNA replication(GO:0033262) |
0.1 | 0.3 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.1 | 0.4 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) positive regulation of sprouting angiogenesis(GO:1903672) |
0.1 | 0.3 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) negative regulation of neural precursor cell proliferation(GO:2000178) |
0.1 | 0.3 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.1 | 0.3 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.1 | 0.6 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
0.1 | 0.3 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.1 | 0.2 | GO:0060027 | convergent extension involved in gastrulation(GO:0060027) |
0.1 | 0.3 | GO:0045112 | integrin biosynthetic process(GO:0045112) |
0.1 | 0.5 | GO:0021978 | telencephalon regionalization(GO:0021978) |
0.1 | 0.9 | GO:0030219 | megakaryocyte differentiation(GO:0030219) |
0.1 | 0.2 | GO:0060900 | optic cup morphogenesis involved in camera-type eye development(GO:0002072) embryonic camera-type eye formation(GO:0060900) |
0.1 | 0.3 | GO:0045627 | positive regulation of T-helper 1 cell differentiation(GO:0045627) |
0.1 | 0.3 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.1 | 0.5 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
0.1 | 0.2 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
0.1 | 0.2 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.1 | 0.5 | GO:0030853 | negative regulation of granulocyte differentiation(GO:0030853) |
0.1 | 0.3 | GO:0090399 | replicative senescence(GO:0090399) |
0.1 | 0.1 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.1 | 0.1 | GO:0072201 | negative regulation of mesenchymal cell proliferation(GO:0072201) |
0.1 | 1.8 | GO:0010811 | positive regulation of cell-substrate adhesion(GO:0010811) |
0.1 | 0.3 | GO:0051497 | negative regulation of stress fiber assembly(GO:0051497) |
0.1 | 0.1 | GO:0060535 | trachea cartilage morphogenesis(GO:0060535) cartilage morphogenesis(GO:0060536) |
0.1 | 0.2 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.1 | 0.2 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.1 | 0.3 | GO:0008218 | bioluminescence(GO:0008218) |
0.1 | 0.5 | GO:0046426 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
0.1 | 0.2 | GO:0010842 | retina layer formation(GO:0010842) |
0.1 | 0.5 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.1 | 0.1 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.1 | 0.4 | GO:1903020 | positive regulation of glycoprotein biosynthetic process(GO:0010560) positive regulation of glycoprotein metabolic process(GO:1903020) |
0.1 | 0.4 | GO:0009103 | lipopolysaccharide biosynthetic process(GO:0009103) |
0.1 | 0.3 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.1 | 1.0 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.1 | 0.2 | GO:0043129 | surfactant homeostasis(GO:0043129) chemical homeostasis within a tissue(GO:0048875) |
0.1 | 0.2 | GO:0033197 | response to vitamin E(GO:0033197) |
0.1 | 0.1 | GO:0060737 | prostate gland morphogenetic growth(GO:0060737) |
0.1 | 0.2 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.1 | 0.1 | GO:0033088 | negative regulation of immature T cell proliferation(GO:0033087) negative regulation of immature T cell proliferation in thymus(GO:0033088) |
0.1 | 2.0 | GO:0001843 | neural tube closure(GO:0001843) tube closure(GO:0060606) |
0.1 | 0.2 | GO:0014912 | negative regulation of smooth muscle cell migration(GO:0014912) |
0.1 | 0.2 | GO:0007412 | axon target recognition(GO:0007412) |
0.1 | 0.2 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.1 | 0.2 | GO:0060297 | regulation of sarcomere organization(GO:0060297) |
0.1 | 0.1 | GO:0046639 | negative regulation of alpha-beta T cell differentiation(GO:0046639) |
0.1 | 0.2 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.1 | 0.4 | GO:0002076 | osteoblast development(GO:0002076) |
0.1 | 0.1 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
0.1 | 0.1 | GO:0060129 | thyroid-stimulating hormone-secreting cell differentiation(GO:0060129) |
0.1 | 0.1 | GO:0001547 | antral ovarian follicle growth(GO:0001547) |
0.1 | 0.2 | GO:0045002 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) double-strand break repair via single-strand annealing(GO:0045002) |
0.1 | 0.2 | GO:0051155 | positive regulation of striated muscle cell differentiation(GO:0051155) |
0.1 | 0.2 | GO:0031657 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031657) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031659) |
0.1 | 0.2 | GO:0071502 | cellular response to temperature stimulus(GO:0071502) |
0.1 | 0.5 | GO:0047496 | vesicle transport along microtubule(GO:0047496) vesicle cytoskeletal trafficking(GO:0099518) |
0.1 | 0.3 | GO:0016246 | RNA interference(GO:0016246) |
0.1 | 0.1 | GO:0090081 | regulation of Wnt signaling pathway involved in heart development(GO:0003307) negative regulation of Wnt signaling pathway involved in heart development(GO:0003308) regulation of heart induction by regulation of canonical Wnt signaling pathway(GO:0090081) |
0.1 | 0.2 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.1 | 0.7 | GO:0032330 | regulation of chondrocyte differentiation(GO:0032330) |
0.1 | 0.1 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
0.0 | 0.0 | GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
0.0 | 0.6 | GO:0007528 | neuromuscular junction development(GO:0007528) |
0.0 | 0.9 | GO:0008038 | neuron recognition(GO:0008038) |
0.0 | 0.1 | GO:0071421 | manganese ion transmembrane transport(GO:0071421) |
0.0 | 0.1 | GO:0072010 | renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
0.0 | 0.1 | GO:0001945 | lymph vessel development(GO:0001945) |
0.0 | 0.0 | GO:0002689 | negative regulation of leukocyte chemotaxis(GO:0002689) |
0.0 | 0.1 | GO:0007184 | SMAD protein import into nucleus(GO:0007184) |
0.0 | 0.1 | GO:1903170 | negative regulation of release of sequestered calcium ion into cytosol(GO:0051280) positive regulation of sequestering of calcium ion(GO:0051284) negative regulation of calcium ion transmembrane transport(GO:1903170) |
0.0 | 2.2 | GO:0034332 | adherens junction organization(GO:0034332) |
0.0 | 0.3 | GO:0035329 | hippo signaling(GO:0035329) |
0.0 | 0.0 | GO:0060242 | contact inhibition(GO:0060242) |
0.0 | 0.2 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.0 | 0.1 | GO:0051968 | positive regulation of synaptic transmission, glutamatergic(GO:0051968) |
0.0 | 0.0 | GO:1903514 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum(GO:0010880) regulation of cardiac muscle contraction by calcium ion signaling(GO:0010882) release of sequestered calcium ion into cytosol by sarcoplasmic reticulum(GO:0014808) calcium ion transport from endoplasmic reticulum to cytosol(GO:1903514) |
0.0 | 0.1 | GO:0006166 | purine ribonucleoside salvage(GO:0006166) |
0.0 | 0.0 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
0.0 | 0.2 | GO:0001885 | endothelial cell development(GO:0001885) |
0.0 | 0.1 | GO:0071731 | response to nitric oxide(GO:0071731) |
0.0 | 0.2 | GO:0034063 | stress granule assembly(GO:0034063) |
0.0 | 0.6 | GO:0048538 | thymus development(GO:0048538) |
0.0 | 0.3 | GO:1901863 | positive regulation of striated muscle tissue development(GO:0045844) positive regulation of muscle organ development(GO:0048636) positive regulation of muscle tissue development(GO:1901863) |
0.0 | 0.4 | GO:0007320 | insemination(GO:0007320) |
0.0 | 0.2 | GO:0008347 | glial cell migration(GO:0008347) |
0.0 | 0.3 | GO:0031000 | response to caffeine(GO:0031000) |
0.0 | 0.0 | GO:0051409 | response to nitrosative stress(GO:0051409) |
0.0 | 0.4 | GO:0006949 | syncytium formation(GO:0006949) |
0.0 | 0.1 | GO:0071379 | cellular response to prostaglandin stimulus(GO:0071379) |
0.0 | 0.1 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.0 | 0.0 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.0 | 0.1 | GO:0060083 | smooth muscle contraction involved in micturition(GO:0060083) |
0.0 | 0.1 | GO:0007500 | mesodermal cell fate determination(GO:0007500) |
0.0 | 0.5 | GO:0014072 | response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
0.0 | 0.2 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
0.0 | 0.1 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.0 | 0.1 | GO:0043268 | positive regulation of potassium ion transport(GO:0043268) |
0.0 | 0.1 | GO:0007598 | blood coagulation, extrinsic pathway(GO:0007598) |
0.0 | 1.1 | GO:0015914 | phospholipid transport(GO:0015914) |
0.0 | 0.1 | GO:0009415 | response to water deprivation(GO:0009414) response to water(GO:0009415) |
0.0 | 0.1 | GO:0051140 | regulation of NK T cell proliferation(GO:0051140) positive regulation of NK T cell proliferation(GO:0051142) |
0.0 | 0.1 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
0.0 | 0.1 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
0.0 | 0.1 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.0 | 0.1 | GO:0035112 | genitalia morphogenesis(GO:0035112) male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.0 | 0.9 | GO:0090090 | negative regulation of canonical Wnt signaling pathway(GO:0090090) |
0.0 | 0.0 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.0 | 0.4 | GO:0043392 | negative regulation of DNA binding(GO:0043392) |
0.0 | 0.5 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) |
0.0 | 0.1 | GO:0021670 | lateral ventricle development(GO:0021670) |
0.0 | 0.2 | GO:0007616 | long-term memory(GO:0007616) |
0.0 | 0.0 | GO:0032352 | positive regulation of hormone metabolic process(GO:0032352) positive regulation of hormone biosynthetic process(GO:0046886) |
0.0 | 0.4 | GO:0046697 | decidualization(GO:0046697) |
0.0 | 0.1 | GO:0045197 | establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
0.0 | 0.1 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.0 | 0.4 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.0 | 0.0 | GO:1901798 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) positive regulation of signal transduction by p53 class mediator(GO:1901798) |
0.0 | 0.1 | GO:0051584 | regulation of neurotransmitter uptake(GO:0051580) regulation of dopamine uptake involved in synaptic transmission(GO:0051584) regulation of catecholamine uptake involved in synaptic transmission(GO:0051940) |
0.0 | 0.2 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
0.0 | 0.1 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.0 | 0.1 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.0 | 0.2 | GO:0048286 | lung alveolus development(GO:0048286) |
0.0 | 0.2 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.0 | 0.1 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.0 | 0.1 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
0.0 | 0.1 | GO:0045992 | negative regulation of embryonic development(GO:0045992) |
0.0 | 0.2 | GO:0072666 | protein targeting to lysosome(GO:0006622) protein targeting to vacuole(GO:0006623) protein localization to lysosome(GO:0061462) protein localization to vacuole(GO:0072665) establishment of protein localization to vacuole(GO:0072666) |
0.0 | 0.1 | GO:0070977 | organ maturation(GO:0048799) bone maturation(GO:0070977) |
0.0 | 0.0 | GO:0002246 | wound healing involved in inflammatory response(GO:0002246) inflammatory response to wounding(GO:0090594) |
0.0 | 0.1 | GO:0018243 | protein O-linked glycosylation via serine(GO:0018242) protein O-linked glycosylation via threonine(GO:0018243) |
0.0 | 0.1 | GO:0051898 | negative regulation of protein kinase B signaling(GO:0051898) |
0.0 | 0.0 | GO:1903670 | regulation of cell migration involved in sprouting angiogenesis(GO:0090049) regulation of sprouting angiogenesis(GO:1903670) |
0.0 | 0.1 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.0 | 0.2 | GO:0045741 | positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
0.0 | 0.2 | GO:0045109 | intermediate filament organization(GO:0045109) |
0.0 | 0.4 | GO:0046068 | cGMP metabolic process(GO:0046068) |
0.0 | 0.6 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.0 | 0.1 | GO:0009138 | pyrimidine nucleoside diphosphate metabolic process(GO:0009138) |
0.0 | 0.1 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.0 | 0.3 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.0 | 0.0 | GO:0071680 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
0.0 | 0.3 | GO:0051101 | regulation of DNA binding(GO:0051101) |
0.0 | 0.1 | GO:0046607 | positive regulation of centrosome cycle(GO:0046607) |
0.0 | 0.0 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.0 | 0.0 | GO:0045920 | negative regulation of exocytosis(GO:0045920) |
0.0 | 0.0 | GO:0030910 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
0.0 | 0.3 | GO:0048566 | embryonic digestive tract development(GO:0048566) |
0.0 | 0.2 | GO:0071479 | cellular response to ionizing radiation(GO:0071479) |
0.0 | 0.5 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.0 | 0.2 | GO:0006264 | mitochondrial DNA replication(GO:0006264) |
0.0 | 0.2 | GO:0006527 | arginine catabolic process(GO:0006527) |
0.0 | 0.1 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.0 | 0.1 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.0 | 0.1 | GO:0090102 | cochlea development(GO:0090102) |
0.0 | 0.1 | GO:0007350 | blastoderm segmentation(GO:0007350) |
0.0 | 0.1 | GO:0048755 | branching morphogenesis of a nerve(GO:0048755) |
0.0 | 0.0 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.0 | 0.1 | GO:0032776 | DNA methylation on cytosine(GO:0032776) C-5 methylation of cytosine(GO:0090116) |
0.0 | 0.2 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.0 | 0.6 | GO:0030318 | melanocyte differentiation(GO:0030318) pigment cell differentiation(GO:0050931) |
0.0 | 0.2 | GO:0001958 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
0.0 | 0.2 | GO:0008228 | opsonization(GO:0008228) |
0.0 | 0.1 | GO:0060644 | mammary gland epithelial cell differentiation(GO:0060644) |
0.0 | 0.1 | GO:0042219 | cellular modified amino acid catabolic process(GO:0042219) |
0.0 | 0.0 | GO:0007132 | meiotic metaphase I(GO:0007132) |
0.0 | 0.3 | GO:0042255 | ribosome assembly(GO:0042255) |
0.0 | 0.0 | GO:0060526 | prostate glandular acinus morphogenesis(GO:0060526) prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis(GO:0060527) |
0.0 | 0.0 | GO:0033688 | regulation of osteoblast proliferation(GO:0033688) |
0.0 | 0.1 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.0 | 0.0 | GO:0032070 | regulation of deoxyribonuclease activity(GO:0032070) |
0.0 | 0.1 | GO:0071436 | sodium ion export(GO:0071436) |
0.0 | 0.0 | GO:0045836 | positive regulation of meiotic nuclear division(GO:0045836) positive regulation of meiotic cell cycle(GO:0051446) |
0.0 | 0.1 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.0 | 0.2 | GO:0043949 | regulation of cAMP-mediated signaling(GO:0043949) |
0.0 | 0.1 | GO:0032310 | regulation of icosanoid secretion(GO:0032303) positive regulation of icosanoid secretion(GO:0032305) regulation of prostaglandin secretion(GO:0032306) positive regulation of prostaglandin secretion(GO:0032308) prostaglandin secretion(GO:0032310) |
0.0 | 0.0 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
0.0 | 0.1 | GO:0006422 | aspartyl-tRNA aminoacylation(GO:0006422) |
0.0 | 0.0 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.0 | 0.1 | GO:0010862 | positive regulation of pathway-restricted SMAD protein phosphorylation(GO:0010862) |
0.0 | 0.1 | GO:0035929 | steroid hormone secretion(GO:0035929) |
0.0 | 0.0 | GO:0060023 | soft palate development(GO:0060023) |
0.0 | 0.0 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.0 | 0.0 | GO:0010511 | regulation of phosphatidylinositol biosynthetic process(GO:0010511) |
0.0 | 0.0 | GO:0055117 | regulation of cardiac muscle contraction(GO:0055117) |
0.0 | 0.1 | GO:0060259 | regulation of feeding behavior(GO:0060259) |
0.0 | 0.1 | GO:0008589 | regulation of smoothened signaling pathway(GO:0008589) |
0.0 | 0.1 | GO:0010042 | response to manganese ion(GO:0010042) |
0.0 | 0.0 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
0.0 | 0.0 | GO:0034201 | response to oleic acid(GO:0034201) |
0.0 | 0.0 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.0 | 0.1 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.0 | 0.1 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.0 | 0.1 | GO:0015871 | choline transport(GO:0015871) |
0.0 | 0.1 | GO:0031054 | pre-miRNA processing(GO:0031054) |
0.0 | 0.1 | GO:0030539 | male genitalia development(GO:0030539) |
0.0 | 0.0 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
0.0 | 0.1 | GO:0010886 | positive regulation of cholesterol storage(GO:0010886) |
0.0 | 0.0 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.0 | 0.1 | GO:0006337 | nucleosome disassembly(GO:0006337) chromatin disassembly(GO:0031498) protein-DNA complex disassembly(GO:0032986) |
0.0 | 0.1 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.0 | 0.0 | GO:0048853 | forebrain morphogenesis(GO:0048853) |
0.0 | 0.1 | GO:0050847 | progesterone receptor signaling pathway(GO:0050847) |
0.0 | 0.1 | GO:0072526 | pyridine-containing compound catabolic process(GO:0072526) |
0.0 | 0.3 | GO:0051353 | positive regulation of oxidoreductase activity(GO:0051353) |
0.0 | 0.1 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.0 | 0.1 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
0.0 | 0.1 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
0.0 | 0.1 | GO:0016322 | neuron remodeling(GO:0016322) |
0.0 | 0.3 | GO:1905037 | autophagosome assembly(GO:0000045) autophagosome organization(GO:1905037) |
0.0 | 0.1 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.0 | 0.0 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
0.0 | 0.1 | GO:0001937 | negative regulation of endothelial cell proliferation(GO:0001937) |
0.0 | 0.1 | GO:0007567 | parturition(GO:0007567) |
0.0 | 0.0 | GO:0009125 | nucleoside monophosphate catabolic process(GO:0009125) |
0.0 | 0.0 | GO:0048263 | determination of dorsal/ventral asymmetry(GO:0048262) determination of dorsal identity(GO:0048263) |
0.0 | 0.0 | GO:2000649 | regulation of sodium:proton antiporter activity(GO:0032415) regulation of sodium ion transmembrane transport(GO:1902305) regulation of sodium ion transmembrane transporter activity(GO:2000649) |
0.0 | 0.0 | GO:0003283 | atrial septum development(GO:0003283) atrial septum morphogenesis(GO:0060413) |
0.0 | 0.1 | GO:0019228 | neuronal action potential(GO:0019228) |
0.0 | 0.2 | GO:0003016 | respiratory system process(GO:0003016) |
0.0 | 0.0 | GO:0051877 | pigment granule aggregation in cell center(GO:0051877) |
0.0 | 0.0 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
0.0 | 0.0 | GO:0010716 | regulation of extracellular matrix disassembly(GO:0010715) negative regulation of extracellular matrix disassembly(GO:0010716) regulation of extracellular matrix organization(GO:1903053) negative regulation of extracellular matrix organization(GO:1903054) |
0.0 | 0.0 | GO:0001696 | gastric acid secretion(GO:0001696) |
0.0 | 0.0 | GO:0046599 | regulation of centriole replication(GO:0046599) |
0.0 | 0.1 | GO:0016115 | diterpenoid catabolic process(GO:0016103) terpenoid catabolic process(GO:0016115) retinoic acid catabolic process(GO:0034653) |
0.0 | 0.0 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
0.0 | 0.1 | GO:0045749 | obsolete negative regulation of S phase of mitotic cell cycle(GO:0045749) |
0.0 | 0.0 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.0 | 0.0 | GO:0022038 | corpus callosum development(GO:0022038) |
0.0 | 0.1 | GO:0045668 | negative regulation of osteoblast differentiation(GO:0045668) |
0.0 | 0.0 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
0.0 | 0.0 | GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II(GO:0019886) |
0.0 | 0.3 | GO:0000038 | very long-chain fatty acid metabolic process(GO:0000038) |
0.0 | 0.1 | GO:0006228 | GTP biosynthetic process(GO:0006183) UTP biosynthetic process(GO:0006228) CTP biosynthetic process(GO:0006241) pyrimidine ribonucleoside triphosphate metabolic process(GO:0009208) pyrimidine ribonucleoside triphosphate biosynthetic process(GO:0009209) CTP metabolic process(GO:0046036) UTP metabolic process(GO:0046051) |
0.0 | 0.0 | GO:0039656 | modulation by virus of host gene expression(GO:0039656) |
0.0 | 0.1 | GO:0035249 | synaptic transmission, glutamatergic(GO:0035249) |
0.0 | 0.0 | GO:0055015 | ventricular cardiac muscle cell development(GO:0055015) |
0.0 | 0.0 | GO:0043032 | positive regulation of macrophage activation(GO:0043032) |
0.0 | 0.1 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
0.0 | 0.1 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.0 | 0.0 | GO:0032656 | regulation of interleukin-13 production(GO:0032656) |
0.0 | 1.8 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.0 | 0.1 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
0.0 | 0.1 | GO:0010799 | regulation of peptidyl-threonine phosphorylation(GO:0010799) positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
0.0 | 0.0 | GO:0072161 | mesenchymal cell differentiation involved in kidney development(GO:0072161) metanephric mesenchymal cell differentiation(GO:0072162) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
0.0 | 0.0 | GO:0033687 | osteoblast proliferation(GO:0033687) |
0.0 | 0.3 | GO:0030520 | intracellular estrogen receptor signaling pathway(GO:0030520) |
0.0 | 0.0 | GO:0047484 | regulation of response to osmotic stress(GO:0047484) |
0.0 | 0.3 | GO:0071805 | cellular potassium ion transport(GO:0071804) potassium ion transmembrane transport(GO:0071805) |
0.0 | 0.0 | GO:0021895 | cerebral cortex neuron differentiation(GO:0021895) |
0.0 | 0.0 | GO:0010901 | regulation of very-low-density lipoprotein particle remodeling(GO:0010901) |
0.0 | 0.1 | GO:0015889 | cobalamin transport(GO:0015889) |
0.0 | 0.1 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
0.0 | 0.0 | GO:0061036 | positive regulation of cartilage development(GO:0061036) |
0.0 | 0.1 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
0.0 | 0.0 | GO:0042748 | circadian sleep/wake cycle, non-REM sleep(GO:0042748) regulation of circadian sleep/wake cycle, non-REM sleep(GO:0045188) |
0.0 | 0.1 | GO:0045040 | outer mitochondrial membrane organization(GO:0007008) protein import into mitochondrial outer membrane(GO:0045040) |
0.0 | 0.1 | GO:0007007 | inner mitochondrial membrane organization(GO:0007007) |
0.0 | 0.0 | GO:0021754 | facial nucleus development(GO:0021754) |
0.0 | 0.4 | GO:0007043 | cell-cell junction assembly(GO:0007043) |
0.0 | 0.1 | GO:0015904 | tetracycline transport(GO:0015904) |
0.0 | 0.0 | GO:0033144 | negative regulation of intracellular steroid hormone receptor signaling pathway(GO:0033144) |
0.0 | 0.0 | GO:0034445 | plasma lipoprotein particle oxidation(GO:0034441) regulation of lipoprotein oxidation(GO:0034442) negative regulation of lipoprotein oxidation(GO:0034443) regulation of plasma lipoprotein particle oxidation(GO:0034444) negative regulation of plasma lipoprotein particle oxidation(GO:0034445) lipoprotein modification(GO:0042160) lipoprotein oxidation(GO:0042161) |
0.0 | 0.1 | GO:0032228 | regulation of synaptic transmission, GABAergic(GO:0032228) |
0.0 | 0.0 | GO:1904181 | positive regulation of mitochondrial depolarization(GO:0051901) positive regulation of membrane depolarization(GO:1904181) |
0.0 | 0.1 | GO:0046622 | positive regulation of organ growth(GO:0046622) |
0.0 | 0.1 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.0 | 0.1 | GO:0007172 | signal complex assembly(GO:0007172) |
0.0 | 0.0 | GO:0090494 | dopamine uptake involved in synaptic transmission(GO:0051583) catecholamine uptake involved in synaptic transmission(GO:0051934) catecholamine uptake(GO:0090493) dopamine uptake(GO:0090494) |
0.0 | 0.3 | GO:0005980 | glycogen catabolic process(GO:0005980) |
0.0 | 0.1 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.0 | 0.0 | GO:0021535 | cell migration in hindbrain(GO:0021535) |
0.0 | 0.3 | GO:0007215 | glutamate receptor signaling pathway(GO:0007215) |
0.0 | 0.3 | GO:0033209 | tumor necrosis factor-mediated signaling pathway(GO:0033209) |
0.0 | 0.1 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
0.0 | 0.0 | GO:0046471 | phosphatidylglycerol biosynthetic process(GO:0006655) cardiolipin metabolic process(GO:0032048) cardiolipin biosynthetic process(GO:0032049) phosphatidylglycerol metabolic process(GO:0046471) |
0.0 | 0.0 | GO:0051451 | myoblast migration(GO:0051451) |
0.0 | 0.0 | GO:0060231 | mesenchymal to epithelial transition(GO:0060231) |
0.0 | 0.1 | GO:0045104 | intermediate filament cytoskeleton organization(GO:0045104) |
0.0 | 0.2 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.0 | 0.1 | GO:0001756 | somitogenesis(GO:0001756) |
0.0 | 0.0 | GO:0046618 | drug export(GO:0046618) |
0.0 | 0.1 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.0 | 0.1 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.0 | 0.1 | GO:0051931 | regulation of sensory perception of pain(GO:0051930) regulation of sensory perception(GO:0051931) |
0.0 | 0.4 | GO:0060070 | canonical Wnt signaling pathway(GO:0060070) |
0.0 | 0.4 | GO:0007219 | Notch signaling pathway(GO:0007219) |
0.0 | 0.0 | GO:0006452 | translational frameshifting(GO:0006452) positive regulation of translational elongation(GO:0045901) positive regulation of translational termination(GO:0045905) |
0.0 | 0.0 | GO:0016266 | O-glycan processing(GO:0016266) |
0.0 | 0.1 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.0 | 0.1 | GO:0090114 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) COPII-coated vesicle budding(GO:0090114) |
0.0 | 0.2 | GO:0042776 | mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
0.0 | 0.1 | GO:0001660 | fever generation(GO:0001660) |
0.0 | 0.0 | GO:0070254 | mucus secretion(GO:0070254) |
0.0 | 0.0 | GO:0002679 | respiratory burst involved in defense response(GO:0002679) |
0.0 | 0.0 | GO:0032410 | negative regulation of transporter activity(GO:0032410) |
0.0 | 0.0 | GO:0042640 | anagen(GO:0042640) |
0.0 | 0.0 | GO:0051459 | corticotropin secretion(GO:0051458) regulation of corticotropin secretion(GO:0051459) positive regulation of corticotropin secretion(GO:0051461) |
0.0 | 0.6 | GO:0007623 | circadian rhythm(GO:0007623) |
0.0 | 0.0 | GO:0032782 | canalicular bile acid transport(GO:0015722) bile acid secretion(GO:0032782) |
0.0 | 0.0 | GO:0030488 | tRNA methylation(GO:0030488) |
0.0 | 0.0 | GO:0014911 | positive regulation of smooth muscle cell migration(GO:0014911) |
0.0 | 0.3 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.0 | 0.1 | GO:0042417 | dopamine metabolic process(GO:0042417) |
0.0 | 0.0 | GO:0033600 | negative regulation of mammary gland epithelial cell proliferation(GO:0033600) |
0.0 | 0.2 | GO:1901343 | negative regulation of vasculature development(GO:1901343) |
0.0 | 0.1 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.0 | 0.0 | GO:0070874 | negative regulation of glycogen metabolic process(GO:0070874) |
0.0 | 0.0 | GO:0060285 | cilium-dependent cell motility(GO:0060285) |
0.0 | 0.0 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.0 | 0.0 | GO:0071392 | cellular response to estradiol stimulus(GO:0071392) |
0.0 | 0.1 | GO:0000090 | mitotic anaphase(GO:0000090) |
0.0 | 0.0 | GO:0034086 | maintenance of sister chromatid cohesion(GO:0034086) maintenance of mitotic sister chromatid cohesion(GO:0034088) |
0.0 | 0.0 | GO:0014821 | phasic smooth muscle contraction(GO:0014821) |
0.0 | 0.0 | GO:1903579 | negative regulation of nucleoside metabolic process(GO:0045978) negative regulation of ATP metabolic process(GO:1903579) |
0.0 | 0.1 | GO:0060079 | excitatory postsynaptic potential(GO:0060079) |
0.0 | 0.1 | GO:0030178 | negative regulation of Wnt signaling pathway(GO:0030178) |
0.0 | 0.0 | GO:0060192 | negative regulation of lipoprotein lipase activity(GO:0051005) negative regulation of lipase activity(GO:0060192) |
0.0 | 0.0 | GO:0021800 | cerebral cortex tangential migration(GO:0021800) |
0.0 | 0.0 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.0 | 0.1 | GO:0051923 | sulfation(GO:0051923) |
0.0 | 0.0 | GO:0033137 | negative regulation of peptidyl-serine phosphorylation(GO:0033137) |
0.0 | 0.4 | GO:0051084 | 'de novo' posttranslational protein folding(GO:0051084) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 0.7 | GO:0030934 | anchoring collagen complex(GO:0030934) |
0.2 | 0.2 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
0.2 | 0.5 | GO:0043259 | laminin-10 complex(GO:0043259) |
0.2 | 0.5 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.2 | 1.0 | GO:0005587 | collagen type IV trimer(GO:0005587) |
0.1 | 0.5 | GO:0005606 | laminin-1 complex(GO:0005606) |
0.1 | 0.4 | GO:0098647 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
0.1 | 0.9 | GO:0005614 | interstitial matrix(GO:0005614) |
0.1 | 0.3 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.1 | 0.4 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.1 | 0.5 | GO:0010369 | chromocenter(GO:0010369) |
0.1 | 0.7 | GO:0016342 | catenin complex(GO:0016342) |
0.1 | 0.6 | GO:0030673 | axolemma(GO:0030673) |
0.1 | 0.7 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.1 | 0.1 | GO:0070852 | cell body fiber(GO:0070852) |
0.1 | 0.5 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.1 | 0.5 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.1 | 0.2 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
0.0 | 0.1 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.0 | 0.2 | GO:0030056 | hemidesmosome(GO:0030056) |
0.0 | 0.8 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.0 | 0.2 | GO:0071437 | invadopodium(GO:0071437) |
0.0 | 0.3 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.0 | 0.8 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.0 | 0.2 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.0 | 0.1 | GO:0070938 | actomyosin contractile ring(GO:0005826) contractile ring(GO:0070938) |
0.0 | 0.2 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.0 | 0.9 | GO:0001725 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.0 | 0.1 | GO:0045298 | tubulin complex(GO:0045298) |
0.0 | 0.1 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.0 | 0.1 | GO:0048179 | activin receptor complex(GO:0048179) |
0.0 | 0.1 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.0 | 0.3 | GO:0014704 | intercalated disc(GO:0014704) cell-cell contact zone(GO:0044291) |
0.0 | 0.6 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.0 | 2.2 | GO:0030426 | growth cone(GO:0030426) |
0.0 | 0.6 | GO:0005811 | lipid particle(GO:0005811) |
0.0 | 0.3 | GO:0000782 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
0.0 | 0.4 | GO:0045263 | proton-transporting ATP synthase complex, coupling factor F(o)(GO:0045263) |
0.0 | 0.2 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.0 | 0.4 | GO:0005884 | actin filament(GO:0005884) |
0.0 | 0.1 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.0 | 0.4 | GO:0098878 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
0.0 | 0.1 | GO:0005787 | signal peptidase complex(GO:0005787) |
0.0 | 0.1 | GO:0071986 | Ragulator complex(GO:0071986) |
0.0 | 0.3 | GO:0042581 | specific granule(GO:0042581) |
0.0 | 1.4 | GO:0005604 | basement membrane(GO:0005604) |
0.0 | 0.0 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.0 | 0.1 | GO:0031512 | motile primary cilium(GO:0031512) |
0.0 | 0.2 | GO:0032589 | neuron projection membrane(GO:0032589) |
0.0 | 0.2 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.0 | 0.2 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.0 | 5.2 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.0 | 0.0 | GO:0045178 | basal part of cell(GO:0045178) |
0.0 | 1.6 | GO:0014069 | postsynaptic density(GO:0014069) postsynaptic specialization(GO:0099572) |
0.0 | 0.1 | GO:0016939 | kinesin II complex(GO:0016939) |
0.0 | 0.0 | GO:0043083 | synaptic cleft(GO:0043083) |
0.0 | 0.1 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.0 | 0.5 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.0 | 0.1 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.0 | 0.1 | GO:0000145 | exocyst(GO:0000145) |
0.0 | 0.5 | GO:0005902 | microvillus(GO:0005902) |
0.0 | 0.1 | GO:0042272 | nuclear RNA export factor complex(GO:0042272) |
0.0 | 0.1 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.0 | 0.1 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.0 | 0.1 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.0 | 0.1 | GO:0005954 | calcium- and calmodulin-dependent protein kinase complex(GO:0005954) |
0.0 | 0.1 | GO:0031941 | filamentous actin(GO:0031941) |
0.0 | 0.6 | GO:0036064 | ciliary basal body(GO:0036064) |
0.0 | 1.5 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.0 | 0.0 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.0 | 0.4 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.0 | 0.0 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.0 | 0.0 | GO:1903561 | extracellular organelle(GO:0043230) extracellular exosome(GO:0070062) extracellular vesicle(GO:1903561) |
0.0 | 0.9 | GO:0043296 | apical junction complex(GO:0043296) |
0.0 | 0.0 | GO:0033643 | host(GO:0018995) host cell part(GO:0033643) host intracellular part(GO:0033646) intracellular region of host(GO:0043656) host cell(GO:0043657) other organism(GO:0044215) other organism cell(GO:0044216) other organism part(GO:0044217) |
0.0 | 0.1 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.0 | 0.1 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.0 | 0.1 | GO:0030686 | 90S preribosome(GO:0030686) |
0.0 | 0.2 | GO:0043195 | terminal bouton(GO:0043195) |
0.0 | 0.1 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.0 | 0.8 | GO:0001726 | ruffle(GO:0001726) |
0.0 | 0.1 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.0 | 0.3 | GO:0034704 | calcium channel complex(GO:0034704) |
0.0 | 0.1 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.0 | 0.3 | GO:0031674 | I band(GO:0031674) |
0.0 | 0.0 | GO:0030427 | site of polarized growth(GO:0030427) |
0.0 | 0.8 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.0 | 0.0 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.0 | 0.1 | GO:0030677 | nucleolar ribonuclease P complex(GO:0005655) ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 2.3 | GO:0001098 | basal transcription machinery binding(GO:0001098) basal RNA polymerase II transcription machinery binding(GO:0001099) |
0.4 | 1.3 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.3 | 1.5 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.2 | 0.9 | GO:0005010 | insulin-like growth factor-activated receptor activity(GO:0005010) |
0.2 | 0.6 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.2 | 1.0 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.2 | 0.6 | GO:0005294 | neutral L-amino acid secondary active transmembrane transporter activity(GO:0005294) |
0.2 | 0.6 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.2 | 1.7 | GO:0003706 | obsolete ligand-regulated transcription factor activity(GO:0003706) |
0.2 | 0.5 | GO:0003680 | AT DNA binding(GO:0003680) |
0.2 | 0.5 | GO:1901474 | azole transporter activity(GO:0045118) azole transmembrane transporter activity(GO:1901474) |
0.2 | 0.6 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.1 | 2.4 | GO:0043498 | obsolete cell surface binding(GO:0043498) |
0.1 | 0.4 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.1 | 0.5 | GO:0016933 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.1 | 0.6 | GO:0042805 | actinin binding(GO:0042805) |
0.1 | 0.4 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.1 | 1.0 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.1 | 0.5 | GO:0005534 | galactose binding(GO:0005534) |
0.1 | 0.3 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.1 | 0.3 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.1 | 0.4 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.1 | 0.4 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.1 | 0.6 | GO:0017166 | vinculin binding(GO:0017166) |
0.1 | 0.5 | GO:0070696 | transmembrane receptor protein serine/threonine kinase binding(GO:0070696) |
0.1 | 0.4 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
0.1 | 0.2 | GO:0004117 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) |
0.1 | 0.4 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.1 | 0.4 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.1 | 0.4 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.1 | 0.5 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.1 | 0.2 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.1 | 0.4 | GO:0042153 | obsolete RPTP-like protein binding(GO:0042153) |
0.1 | 0.2 | GO:0070215 | obsolete MDM2 binding(GO:0070215) |
0.1 | 0.4 | GO:0005499 | vitamin D binding(GO:0005499) |
0.1 | 0.4 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.1 | 1.0 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.1 | 0.2 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.1 | 0.3 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.1 | 0.7 | GO:0001968 | fibronectin binding(GO:0001968) |
0.1 | 0.3 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.1 | 0.2 | GO:0016215 | stearoyl-CoA 9-desaturase activity(GO:0004768) acyl-CoA desaturase activity(GO:0016215) |
0.1 | 0.3 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.1 | 0.2 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.1 | 0.7 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.1 | 0.1 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.1 | 0.3 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.1 | 0.2 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.1 | 0.3 | GO:0031994 | insulin-like growth factor I binding(GO:0031994) |
0.1 | 1.3 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.1 | 0.3 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
0.1 | 0.7 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.1 | 0.4 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.1 | 0.3 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.1 | 1.7 | GO:0005518 | collagen binding(GO:0005518) |
0.1 | 1.0 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.1 | 0.2 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.1 | 0.1 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.0 | 0.0 | GO:0043175 | RNA polymerase core enzyme binding(GO:0043175) |
0.0 | 0.4 | GO:0048185 | activin binding(GO:0048185) |
0.0 | 0.2 | GO:0030235 | nitric-oxide synthase regulator activity(GO:0030235) |
0.0 | 0.1 | GO:0043398 | HLH domain binding(GO:0043398) |
0.0 | 0.1 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.0 | 0.2 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) |
0.0 | 0.1 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.0 | 0.5 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.0 | 0.7 | GO:0045296 | cadherin binding(GO:0045296) |
0.0 | 0.2 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.0 | 0.3 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.0 | 0.1 | GO:0032052 | bile acid binding(GO:0032052) |
0.0 | 0.8 | GO:0050699 | WW domain binding(GO:0050699) |
0.0 | 0.1 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.0 | 0.1 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
0.0 | 0.2 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.0 | 0.2 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.0 | 0.4 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.0 | 0.1 | GO:0019958 | C-X-C chemokine binding(GO:0019958) interleukin-8 binding(GO:0019959) |
0.0 | 0.1 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.0 | 0.3 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.0 | 0.2 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.0 | 0.2 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.0 | 0.1 | GO:0030172 | troponin C binding(GO:0030172) |
0.0 | 0.1 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.0 | 0.1 | GO:0016847 | 1-aminocyclopropane-1-carboxylate synthase activity(GO:0016847) |
0.0 | 0.1 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.0 | 0.1 | GO:0031708 | bombesin receptor binding(GO:0031705) endothelin B receptor binding(GO:0031708) |
0.0 | 0.2 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.0 | 0.1 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.0 | 0.2 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.0 | 0.2 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.0 | 0.3 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.0 | 0.1 | GO:0034711 | inhibin binding(GO:0034711) |
0.0 | 0.5 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.0 | 0.3 | GO:0016565 | obsolete general transcriptional repressor activity(GO:0016565) |
0.0 | 0.2 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.0 | 0.6 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.0 | 0.1 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.0 | 0.1 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.0 | 0.2 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.0 | 0.2 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.0 | 0.1 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.0 | 1.8 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.0 | 0.3 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.0 | 0.1 | GO:0004064 | arylesterase activity(GO:0004064) |
0.0 | 0.3 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.0 | 0.3 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.0 | 0.1 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.0 | 0.1 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.0 | 0.1 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.0 | 0.3 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) |
0.0 | 0.1 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.0 | 0.3 | GO:0030553 | cGMP binding(GO:0030553) |
0.0 | 0.2 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.0 | 0.2 | GO:0051378 | serotonin binding(GO:0051378) |
0.0 | 0.1 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.0 | 0.4 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.0 | 0.3 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.0 | 0.5 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.0 | 0.1 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.0 | 0.5 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.0 | 0.2 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.0 | 0.1 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.0 | 0.1 | GO:0004945 | angiotensin receptor activity(GO:0001595) angiotensin type II receptor activity(GO:0004945) |
0.0 | 0.2 | GO:0070717 | poly-purine tract binding(GO:0070717) |
0.0 | 0.0 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.0 | 0.1 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
0.0 | 0.1 | GO:0004083 | bisphosphoglycerate mutase activity(GO:0004082) bisphosphoglycerate 2-phosphatase activity(GO:0004083) phosphoglycerate mutase activity(GO:0004619) |
0.0 | 0.1 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.0 | 0.1 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.0 | 0.1 | GO:0000982 | transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0000982) transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
0.0 | 0.1 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.0 | 0.1 | GO:0004815 | aspartate-tRNA ligase activity(GO:0004815) |
0.0 | 0.1 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) |
0.0 | 0.1 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.0 | 0.1 | GO:0070628 | proteasome binding(GO:0070628) |
0.0 | 0.1 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.0 | 0.1 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.0 | 0.3 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.0 | 0.0 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
0.0 | 0.5 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
0.0 | 0.1 | GO:0045545 | syndecan binding(GO:0045545) |
0.0 | 0.1 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
0.0 | 0.1 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.0 | 0.1 | GO:0005110 | frizzled-2 binding(GO:0005110) |
0.0 | 0.1 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
0.0 | 2.5 | GO:0008083 | growth factor activity(GO:0008083) |
0.0 | 0.1 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.0 | 0.2 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.0 | 0.0 | GO:0030911 | TPR domain binding(GO:0030911) |
0.0 | 0.3 | GO:0004407 | histone deacetylase activity(GO:0004407) |
0.0 | 0.4 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.0 | 0.2 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.0 | 0.1 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.0 | 0.1 | GO:0004525 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
0.0 | 0.1 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.0 | 0.1 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.0 | 0.0 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) ATP-dependent microtubule motor activity(GO:1990939) |
0.0 | 0.1 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.0 | 0.1 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
0.0 | 0.1 | GO:0015307 | drug:proton antiporter activity(GO:0015307) |
0.0 | 0.1 | GO:0033765 | steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) |
0.0 | 0.1 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.0 | 0.1 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
0.0 | 0.2 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.0 | 0.3 | GO:0030145 | manganese ion binding(GO:0030145) |
0.0 | 0.1 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.0 | 0.1 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.0 | 0.2 | GO:0031490 | chromatin DNA binding(GO:0031490) |
0.0 | 0.2 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.0 | 0.0 | GO:0042910 | xenobiotic-transporting ATPase activity(GO:0008559) xenobiotic transporter activity(GO:0042910) |
0.0 | 0.1 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.0 | 0.0 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.0 | 0.0 | GO:0043734 | DNA demethylase activity(GO:0035514) DNA-N1-methyladenine dioxygenase activity(GO:0043734) |
0.0 | 0.1 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.0 | 0.1 | GO:0009374 | biotin binding(GO:0009374) |
0.0 | 0.0 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.0 | 0.1 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
0.0 | 0.1 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.0 | 0.1 | GO:0000977 | RNA polymerase II regulatory region sequence-specific DNA binding(GO:0000977) RNA polymerase II regulatory region DNA binding(GO:0001012) |
0.0 | 0.2 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.0 | 0.1 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
0.0 | 0.0 | GO:0000976 | transcription regulatory region sequence-specific DNA binding(GO:0000976) |
0.0 | 0.0 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.0 | 0.1 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.0 | 0.1 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.0 | 0.1 | GO:0099589 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.0 | 0.1 | GO:0050780 | dopamine receptor binding(GO:0050780) |
0.0 | 0.1 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.0 | 0.0 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.0 | 1.4 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 0.1 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.0 | 0.0 | GO:0016314 | phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity(GO:0016314) |
0.0 | 0.1 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.0 | 0.0 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.0 | 0.1 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.0 | 0.1 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.0 | 0.2 | GO:0008483 | transaminase activity(GO:0008483) |
0.0 | 0.3 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.0 | 0.0 | GO:0019863 | IgE binding(GO:0019863) |
0.0 | 0.0 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.0 | 0.0 | GO:0047115 | trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity(GO:0047115) |
0.0 | 0.1 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.0 | 0.0 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.0 | 0.0 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.0 | 0.0 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.0 | 0.7 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.0 | 0.5 | GO:0008237 | metallopeptidase activity(GO:0008237) |
0.0 | 0.0 | GO:0031420 | alkali metal ion binding(GO:0031420) |
0.0 | 0.1 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.0 | 0.1 | GO:0070402 | NADPH binding(GO:0070402) |
0.0 | 0.0 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.0 | 0.1 | GO:0004970 | ionotropic glutamate receptor activity(GO:0004970) |
0.0 | 0.2 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 1.4 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.1 | 0.2 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.1 | 1.0 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.1 | 0.6 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.1 | 2.8 | NABA COLLAGENS | Genes encoding collagen proteins |
0.1 | 2.7 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.1 | 1.0 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.0 | 0.6 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.0 | 0.7 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.0 | 1.4 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.0 | 0.6 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.0 | 1.6 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.0 | 0.0 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.0 | 0.3 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.0 | 0.1 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.0 | 0.1 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.0 | 0.8 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.0 | 0.4 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.0 | 0.3 | PID CDC42 PATHWAY | CDC42 signaling events |
0.0 | 1.1 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.0 | 0.0 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.0 | 0.1 | PID ALK1 PATHWAY | ALK1 signaling events |
0.0 | 0.5 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.0 | 0.0 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.0 | 0.7 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.0 | 0.2 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.0 | 0.1 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.0 | 3.2 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 0.3 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.0 | 0.2 | PID ALK2 PATHWAY | ALK2 signaling events |
0.0 | 0.3 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.0 | 0.2 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.0 | 0.5 | PID NOTCH PATHWAY | Notch signaling pathway |
0.0 | 0.2 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.0 | 0.8 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.0 | 0.5 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.0 | 2.6 | NABA CORE MATRISOME | Ensemble of genes encoding core extracellular matrix including ECM glycoproteins, collagens and proteoglycans |
0.0 | 0.5 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.0 | 0.0 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.0 | 0.1 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.0 | 3.9 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.0 | 0.0 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.0 | 2.8 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 0.3 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.0 | 0.1 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.0 | 0.2 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.0 | 0.2 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.0 | 0.3 | PID BMP PATHWAY | BMP receptor signaling |
0.0 | 0.6 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.0 | 0.2 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.0 | 0.1 | PID FGF PATHWAY | FGF signaling pathway |
0.0 | 0.0 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.0 | 0.2 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.0 | 0.1 | PID INSULIN PATHWAY | Insulin Pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 3.5 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.2 | 0.8 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.2 | 4.3 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.1 | 1.3 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.1 | 0.1 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII | Genes involved in CREB phosphorylation through the activation of CaMKII |
0.1 | 2.3 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.1 | 1.3 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.1 | 2.1 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.1 | 0.7 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.1 | 0.9 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.1 | 0.3 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.1 | 0.8 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.1 | 0.6 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.1 | 0.1 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
0.1 | 0.8 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.1 | 0.5 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.1 | 2.8 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.0 | 0.6 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.0 | 0.8 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
0.0 | 1.0 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.0 | 1.3 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.0 | 0.1 | REACTOME SHC MEDIATED SIGNALLING | Genes involved in SHC-mediated signalling |
0.0 | 0.1 | REACTOME TRANSPORT OF RIBONUCLEOPROTEINS INTO THE HOST NUCLEUS | Genes involved in Transport of Ribonucleoproteins into the Host Nucleus |
0.0 | 0.0 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.0 | 0.0 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.0 | 0.4 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.0 | 0.4 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.0 | 0.4 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.0 | 0.8 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.0 | 0.4 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.0 | 0.3 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.0 | 0.3 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.0 | 0.0 | REACTOME G1 S TRANSITION | Genes involved in G1/S Transition |
0.0 | 1.4 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.0 | 0.4 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.0 | 0.6 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.0 | 0.3 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.0 | 0.1 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.0 | 0.3 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
0.0 | 0.0 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.0 | 0.4 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.0 | 0.3 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.0 | 0.2 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.0 | 0.7 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.0 | 0.4 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.0 | 0.5 | REACTOME ION CHANNEL TRANSPORT | Genes involved in Ion channel transport |
0.0 | 0.3 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.0 | 0.6 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
0.0 | 0.6 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.0 | 0.0 | REACTOME REGULATION OF APOPTOSIS | Genes involved in Regulation of Apoptosis |
0.0 | 0.1 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.0 | 0.3 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.0 | 0.3 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.0 | 0.3 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.0 | 0.1 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.0 | 0.1 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.0 | 1.0 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.0 | 0.2 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.0 | 0.1 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.0 | 0.1 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.0 | 0.3 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.0 | 0.6 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.0 | 0.1 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.0 | 0.2 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.0 | 0.3 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.0 | 0.3 | REACTOME EXTRACELLULAR MATRIX ORGANIZATION | Genes involved in Extracellular matrix organization |
0.0 | 0.2 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.0 | 0.1 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.0 | 0.1 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.0 | 0.2 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.0 | 0.2 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.0 | 0.1 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.0 | 0.1 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.0 | 0.0 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.0 | 0.1 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.0 | 0.1 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |